These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 17243140

  • 1. 5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review.
    Gisbert JP, González-Lama Y, Maté J.
    Inflamm Bowel Dis; 2007 May; 13(5):629-38. PubMed ID: 17243140
    [Abstract] [Full Text] [Related]

  • 2. Effect of 5-aminosalicylates on renal function in patients with inflammatory bowel disease: 4-year follow-up study.
    Gisbert JP, Luna M, González-Lama Y, Pousa ID, Velasco M, Moreno-Otero R, Maté J.
    Gastroenterol Hepatol; 2008 Oct; 31(8):477-84. PubMed ID: 18928745
    [Abstract] [Full Text] [Related]

  • 3. Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.
    Heap GA, So K, Weedon M, Edney N, Bewshea C, Singh A, Annese V, Beckly J, Buurman D, Chaudhary R, Cole AT, Cooper SC, Creed T, Cummings F, de Boer NK, D'Inca R, D'Souza R, Daneshmend TK, Delaney M, Dhar A, Direkze N, Dunckley P, Gaya DR, Gearry R, Gore S, Halfvarson J, Hart A, Hawkey CJ, Hoentjen F, Iqbal T, Irving P, Lal S, Lawrance I, Lees CW, Lockett M, Mann S, Mansfield J, Mowat C, Mulgrew CJ, Muller F, Murray C, Oram R, Orchard T, Parkes M, Phillips R, Pollok R, Radford-Smith G, Sebastian S, Sen S, Shirazi T, Silverberg M, Solomon L, Sturniolo GC, Thomas M, Tremelling M, Tsianos EV, Watts D, Weaver S, Weersma RK, Wesley E, Holden A, Ahmad T.
    J Crohns Colitis; 2016 Feb; 10(2):149-58. PubMed ID: 26619893
    [Abstract] [Full Text] [Related]

  • 4. Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease.
    Corrigan G, Stevens PE.
    Aliment Pharmacol Ther; 2000 Jan; 14(1):1-6. PubMed ID: 10632639
    [Abstract] [Full Text] [Related]

  • 5. 5-ASA induced interstitial nephritis in patients with inflammatory bowel disease: a systematic review.
    Moss JG, Parry CM, Holt RCL, McWilliam SJ.
    Eur J Med Res; 2022 Apr 29; 27(1):61. PubMed ID: 35488310
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mesalazine-associated interstitial nephritis.
    World MJ, Stevens PE, Ashton MA, Rainford DJ.
    Nephrol Dial Transplant; 1996 Apr 29; 11(4):614-21. PubMed ID: 8671848
    [Abstract] [Full Text] [Related]

  • 10. Chronic interstitial nephritis due to 5-aminosalicylic acid.
    Agharazii M, Marcotte J, Boucher D, Noël R, Lebel M.
    Am J Nephrol; 1999 Apr 29; 19(3):373-6. PubMed ID: 10393373
    [Abstract] [Full Text] [Related]

  • 11. Renal effects of long-term treatment with 5-aminosalicylic acid.
    Patel H, Barr A, Jeejeebhoy KN.
    Can J Gastroenterol; 2009 Mar 29; 23(3):170-6. PubMed ID: 19319380
    [Abstract] [Full Text] [Related]

  • 12. Acute interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease.
    Frandsen NE, Saugmann S, Marcussen N.
    Nephron; 2002 Sep 29; 92(1):200-2. PubMed ID: 12187103
    [Abstract] [Full Text] [Related]

  • 13. Pediatric case of mesalazine-induced interstitial nephritis with literature review.
    Co ML, Gorospe EC.
    Pediatr Int; 2013 Jun 29; 55(3):385-7. PubMed ID: 23782372
    [Abstract] [Full Text] [Related]

  • 14. 5-ASA therapy and renal function in inflammatory bowel disease.
    Siveke JT, Egert J, Sitter T, Schiemann U, Walcher P, Török HP, Glas J, Folwaczny C.
    Am J Gastroenterol; 2005 Feb 29; 100(2):501. PubMed ID: 15667517
    [No Abstract] [Full Text] [Related]

  • 15. The Association of Mesalamine With Kidney Disease.
    Adiga A, Goldfarb DS.
    Adv Chronic Kidney Dis; 2020 Jan 29; 27(1):72-76. PubMed ID: 32147005
    [Abstract] [Full Text] [Related]

  • 16. Relapsing tubulointerstitial nephritis in an adolescent with inflammatory bowel disease without aminosalicylate exposure.
    Shahrani Muhammad HS, Peters C, Casserly LF, Dorman AM, Watts M.
    Clin Nephrol; 2010 Mar 29; 73(3):250-2. PubMed ID: 20178728
    [Abstract] [Full Text] [Related]

  • 17. Interstitial nephritis in patients with inflammatory bowel disease treated with mesalamine.
    Margetts PJ, Churchill DN, Alexopoulou I.
    J Clin Gastroenterol; 2001 Feb 29; 32(2):176-8. PubMed ID: 11205659
    [Abstract] [Full Text] [Related]

  • 18. [Severe tubulo-interstitial nephritis secondary to 5-ASA].
    Bosque López MJ, Garrido Durán C, Ginard Vicens D, Munar Vila MA, Vanrell Garau M, Mariño Méndez Z, Gayà Cantallops J.
    Gastroenterol Hepatol; 2009 Jan 29; 32(1):29-31. PubMed ID: 19174096
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.